Given the significant roles of DUSP6 and PDIA4 in both IBD and RA, could they serve as predictive biomarkers or therapeutic targets for these diseases, and how do they affect their pathogenesis? This evidence concerns the gene DUSP6 and rheumatoid arthritis.